DrugPatentWatch Database Preview
CUVPOSA Drug Profile
Email this page to a colleague
» See Plans and PricingWhich patents cover Cuvposa, and what generic alternatives are available?
Cuvposa is a drug marketed by Merz Pharms and is included in one NDA. There are two patents protecting this drug and one Paragraph IV challenge.
The generic ingredient in CUVPOSA is glycopyrrolate. There are seventeen drug master file entries for this compound. Forty-one suppliers are listed for this compound. Additional details are available on the glycopyrrolate profile page.
US ANDA Litigation and Generic Entry Outlook for Cuvposa
A generic version of CUVPOSA was approved as glycopyrrolate by AM REGENT on July 23rd, 1986.
Summary for CUVPOSA
| US Patents: | 2 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 1 |
| Bulk Api Vendors: | 78 |
| Patent Applications: | 2,536 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for CUVPOSA |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for CUVPOSA |
| DailyMed Link: | CUVPOSA at DailyMed |
Pharmacology for CUVPOSA
| Drug Class | Anticholinergic |
| Mechanism of Action | Cholinergic Antagonists |
Paragraph IV (Patent) Challenges for CUVPOSA
| Tradename | Dosage | Ingredient | NDA | Submissiondate |
|---|---|---|---|---|
| CUVPOSA | SOLUTION;ORAL | glycopyrrolate | 022571 | 2012-06-20 |
US Patents and Regulatory Information for CUVPOSA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Merz Pharms | CUVPOSA | glycopyrrolate | SOLUTION;ORAL | 022571-001 | Jul 28, 2010 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
| Merz Pharms | CUVPOSA | glycopyrrolate | SOLUTION;ORAL | 022571-001 | Jul 28, 2010 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
